Sanofi Survey Finds Travel Puts Those with Severe Allergies on High Alert 20 Aug 2013 | 05:00 pm

- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling -

Sanofi Q2 2013: Last Quarter with Significant Negative Impact from the Patent Cliff 1 Aug 2013 | 04:00 pm

FDA Advisory Committee Recommends Approval of Sanofi's Nasacort® AQ Nasal Spray for Over-the-Counter Use 1 Aug 2013 | 02:45 am

- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children -

Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300 22 Jun 2013 | 08:26 pm

- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® -

Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions 22 Jun 2013 | 08:03 pm

Cities for Life Highlights Diabetes Management in Birmingham at American Diabetes Association 73rd Scientific Sessions 22 Jun 2013 | 08:02 pm

Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes 22 Jun 2013 | 08:01 pm

-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents --

Sanofi US Announces Winner of 2013 Data Design Diabetes Innovation Challenge -- Prove It! 4 Jun 2013 | 07:30 pm

- Connect & Coach™ Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes -

Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month 16 May 2013 | 05:00 pm

- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action -

New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem 7 May 2013 | 12:00 am

The same trusted formula in an easy aim spray